Neill Andrew R 4

What Happened Neill Andrew R, Chief Financial Officer of Shattuck Labs (STTK), exercised previously held warrants and acquired 64,027 shares of common stock on 2026-05-12. The acquisition was reported as an "A" (award/acquisition) of 64,027 shares at $1.08 per share for a total reported cost of $69,444. The filing also records an "M" (exercise/conversion of a derivative) for 64,027 shares, indicating the underlying warrants were converted/used in the transaction.

Key Details

• Transaction date: 2026-05-12; Filing date (Accession): 2026-05-14 (filed two days after the transaction).
• Acquired: 64,027 shares at $1.08/share; total reported purchase amount $69,444.
• Derivative: 64,027-warrant position was exercised/converted (M code); exercise price shown as N/A in the derivative line because the derivative instrument was disposed (warrant extinguished) in the conversion.
• Shares owned after transaction: Not disclosed in the provided excerpt.
• Footnote summary:
  • F1: These shares/warrants trace to a private placement closed Aug 25, 2025; the Reporting Person purchased 64,027 shares and accompanying warrants at a combined price per share+Warrant of $0.8677.
  • F2: The warrants are exercisable until 30 days after certain Phase 1 clinical trial data and Phase 2 design have been publicly announced.

Context

• This was an exercise/conversion of warrants into common stock (derivative -> shares), not an open-market buy or sale. The warrants extinguished upon conversion; the record shows the CFO ended up with the newly issued common shares.
• The dollar amount is modest (~$69k). The filing appears timely (reported two days after the trade), and there is no indication of a 10b5-1 plan, tax withholding, or gift involved in the disclosed entries.